Digestive properties and effects of Chimonanthus nitens Oliv polysaccharides on antioxidant effects in vitro and in immunocompromised mice

Int J Biol Macromol. 2021 Aug 31:185:306-316. doi: 10.1016/j.ijbiomac.2021.06.114. Epub 2021 Jun 22.

Abstract

The study was aimed to investigate the simulated digestion behavior of the bioactive polysaccharides from Chimonanthus nitens Oliv (COP1), antioxidant activity in vitro, and prevention against cyclophosphamide (CP) induced oxidative damage in mice. The results showed that COP1 were 18.843 kDa, and consisted of arabinose (56.6 mol%), galactose (24.9 mol%), xylose (11.1 mol%), and glucose (7.4 mol%). Gastrointestinal digestion significantly improved the radical (DPPH, OH, and ABTS+) scavenging activities of COP1. Meanwhile, administration of COP1 (150, 300, and 600 mg/kg, continuous 16 days) prevented hepatotoxicity in CP-induced mice (reducing liver index and transaminase levels, alleviating liver damage). COP1 also attenuated oxidative stress as evident from as shown by reduced levels of MDA and enhanced activity of antioxidant enzymes (CAT, SOD, and GSH-Px). In addition, COP1 regulated the Nrf2/Keap1 signaling pathway in CP-treated mice, decreasing the upstream factor Keap1 and increasing the upstream factor Nrf2, which in turn enhanced the expression of downstream factors (NQO1, HO-1, GSH-Px, SOD1, and CAT). COP1 also protected the body from CP-induced oxidative damage by down-regulating Bax and caspase3 in the apoptosis pathway and up-regulating Bcl-2 mRNA levels. Overall, COP1 might be harnessed as an effective natural antioxidant for medical and food industries.

Keywords: Antioxidant activity; Chimonanthus nitens Oliv; In vitro digestion; Polysaccharides.

MeSH terms

  • Animals
  • Antioxidants / administration & dosage*
  • Antioxidants / chemistry
  • Antioxidants / pharmacology
  • Calycanthaceae / chemistry*
  • Chemical and Drug Induced Liver Injury / drug therapy*
  • Chemical and Drug Induced Liver Injury / genetics
  • Chemical and Drug Induced Liver Injury / metabolism
  • Cyclophosphamide / adverse effects*
  • Disease Models, Animal
  • Female
  • Gene Expression Regulation / drug effects
  • Immunocompromised Host
  • Malondialdehyde / metabolism
  • Mice
  • Oxidative Stress / drug effects
  • Polysaccharides / administration & dosage*
  • Polysaccharides / chemistry
  • Polysaccharides / pharmacology
  • Signal Transduction / drug effects

Substances

  • Antioxidants
  • Polysaccharides
  • Malondialdehyde
  • Cyclophosphamide